Locally advanced intrahepatic cholangiocarcinoma successfully resected after transcatheter arterial chemoembolization with degradable starch microspheres: Report of a case

Hepato-Gastroenterology

Volumn 54, Issue 77, 2007, Pages 1345-1347

  Wu, Yongyou ^a,b   Saiura, Akio ^a   Yamamoto, Junji ^a   Koga, Rintaro ^a   Asahara, Shingo ^a   Kamei, Akira ^a   Takano, Koichi ^a   Ikari, Takaaki ^a   Seki, Makoto ^a   Yamaguchi, Toshiharu ^a   Muto, Tetsuichiro ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Degradable starch Microspheres; Intrahepatic cholangiocarcinoma; Liver resection

Indexed keywords

EPIRUBICIN; MITOMYCIN C; STARCH MICROSPHERE;

ABSENCE OF SIDE EFFECTS; ADVANCED CANCER; AGED; ARTERIOGRAPHY; ARTICLE; BILE DUCT CARCINOMA; CANCER LOCALIZATION; CANCER REGRESSION; CANCER SIZE; CANCER SURGERY; CASE REPORT; CHEMOEMBOLIZATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DOSE RESPONSE; FEMALE; HUMAN; LABORATORY TEST; PATIENT REFERRAL; PRIORITY JOURNAL; TREATMENT OUTCOME; VASCULARIZATION;

AGED; ARTERIES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CATHETERIZATION; CHEMOEMBOLIZATION, THERAPEUTIC; CHOLANGIOCARCINOMA; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; MICROSPHERES; REMISSION INDUCTION; STARCH;

EID: 34547632524     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Ikai I, Arii S, Ichida T, Okita K, Omata M, Kojiro M, Takayasu K, et al: Report of the 16th follow-up survey of primary liver cancer. Hepatol Res 2005; 32:163-172.
2. Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T, Fujikawa M, et al: Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2003; 10:432-440.
3. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC: Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 2002; 37:806-813.
4. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33:1353-1357.
5. Patel T: Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2:10.
6. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, et al: Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224:463-473; discussion 473-465.
7. Anderson CD, Pinson CW, Berlin J, Chari RS: Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004; 9:43-57.
8. Carriaga MT, Henson DE: Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995; 75:171-190.
9. Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, Okumura T, et al: Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg 2002; 26:687-693.
10. Chu KM, Fan ST: Intrahepatic cholangiocarcinoma in Hong Kong. J Hepatobiliary Pancreat Surg 1999; 6:149-153.
11. Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita Y, Tsujita E, Aishima S: Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery 2002; 131:S159-164.
12. Chang D, Jenkins SA, Grime SJ, Nott DM, Cooke T: Increasing hepatic arterial flow to hypovascular hepatic tumours using degradable starch microspheres. Br J Cancer 1996; 73:961-965.
13. Nakajima T, Nozu S, Saitou AY, Okayasu K, Majima T, Yagi A: [Clinical effectiveness of intra-arterial chemotherapy combined with degradable starch microspheres (DSM) for liver metastases and prediction of effectiveness by diagnostic imaging]. Gan To Kagaku Ryoho 2001; 28:1489-1492.
14. Hirai K, Yamashita K, Aoki Y, Sakai T, Abe M, Tanikawa K, Noguchi H, et al: [An assessment of therapeutic effects by transcatheter arterial embolization (TAB) with degradable starch microspheres (DSM) for hepatic malignant tumors]. Nippon Gan Chiryo Gakkai Shi 1989; 24:772-780.
15. Pohlen U, Mansmann U, Berger G, Germer CT, Gallkowski U, Boese-Landgraf J, Buhr HJ: Multicenter pilot study of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres via hepatic arterial infusion in patients with nonresectable colorectal liver metastases. Anticancer Res 2004; 24:3275-3282.
16. Furuse J, Ishii H, Satake M, Onaya H, Nose H, Mikami S, Sakai H, et al: Pilot study of transcatheter arterial chemoembolization with degradable starch microspheres in patients with hepatocellular carcinoma. Am J Clin Oncol 2003; 26:159-164.